-- 中国水務（香港証券取引所：0855）は、2030年満期の年利5.875%のシニア債1億5000万米ドルを追加発行すると、水曜日に香港証券取引所に提出した書類で明らかにした。 提出書類によると、この追加発行債は、同社が2025年10月に発行した既存の1億5000万米ドルの債券と統合され、単一シリーズとなる。 債券の発行価格は元本額の95.384%で、年利5.875%のクーポンが付帯し、満期日は2030年10月22日となる。 同社は、調達資金を同時実施中の公開買付けの資金と一部の海外債務の返済に充当し、残りの資金は、同社のグリーン＆ブルーファイナンス・フレームワークに基づき、特に給水プロジェクトなどの適格なグリーンプロジェクトに充当する予定である。
Related Articles
Asia
JCET's Q1 Profit Jumps 43%, Revenue Slips 2%
JCET's (SHA:600584) net profit attributable to shareholders in the first quarter jumped 43% to 290.3 million yuan from 203.4 million yuan a year earlier, according to a Shanghai bourse filing on Wednesday.Earnings per share rose 45% year on year to 0.16 yuan from 0.11 yuan.Operating revenue slipped 1.8% to 9.17 billion yuan from 9.34 billion yuan in the preceding year.The shares of the Chinese integrated circuit manufacturer dropped less than 3% during midday trade.
$SHA:600584
Asia
Update: G8 Education to Suspend Operation of Around 40 Centers, Shares Reach 16-Year Low
(Updates to add the stock movement in the sixth paragraph)G8 Education (ASX:GEM) plans to suspend the operation of around 40 of its centers as a result of an assessment of its network, according to a Wednesday Australian bourse filing.It will transition customers to one of the nearby centers and, where possible, redeploy team members. The firm will then consider longer-term options for those centers, including lease surrender, divestment, or other alternatives.The firm will also reorganize its support office structure and reduce its cost base.Its current spot occupancy as of April 24 came in at 56.4%, down 7% year-over-year, while year-to-date occupancy was 56.1%, down 7.9% versus the prior corresponding period.Occupancy across the early childhood education and care sector is lower compared to previous years due to sustained affordability pressures, falling birth rates, increased long-day care supply, and confidence impacted by serious child safety incidents, the filing noted.Its shares fell 25% in recent trading on Wednesday, earlier reaching a 16-year low.
$ASX:GEM
Asia
Fosun Pharmaceutical Reports 14% Higher Profit in Q1
Shanghai Fosun Pharmaceutical (SHA:600196, HKG:2196) logged a 14% rise in its attributable profit for the first quarter of 2026 to 870.8 million yuan from 764.8 million yuan a year earlier, according to a Hong Kong bourse filing Tuesday.The pharmaceutical company's Hong Kong shares fell nearly 2% in late morning trade Wednesday.Earnings per share were 0.33 yuan, compared with 0.29 yuan in the prior year.Operating revenue gained nearly 7% to 10.1 billion yuan, figures showed.
$HKG:2196$SHA:600196